Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HuCNS-SC in Thoracic Spinal Cord Injury
NCT01321333Phase 2Completed
- Sponsor
- StemCells, Inc.
- Start
- Mar 2011
- Primary completion
- Apr 2015
- Modality
- Stem Cell Therapies
- Countries
- 2
01
Overview
A Phase 2 trial of HuCNS-SC in thoracic spinal cord injury (TSCI), sponsored by StemCells, Inc.. Started Mar 2011; status: completed.
02
Drugs
HuCNS-SC
03
Conditions
thoracic spinal cord injury (TSCI)
Beyond the preview
Go deeper on NCT01321333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01321333.